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Abstract
Objective: Historically, management of infants with fever without localizing signs (FWLS) has generated much controversy,
with attempts to risk stratify based on several criteria. Advances in medical practice may have altered the epidemiology of
serious bacterial infections (SBIs) in this population. We conducted this study to test the hypothesis that the rate of SBIs in
this patient population has changed over time.
Patients and Methods: We performed a retrospective review of all infants meeting FWLS criteria at our institution from
1997–2006. We examined all clinical and outcome data and performed statistical analysis of SBI rates and ampicillin
resistance rates.
Results: 668 infants met criteria for FWLS. The overall rate of SBIs was 10.8%, with a significant increase from 2002–2006 (52/
361, 14.4%) compared to 1997–2001 (20/307, 6.5%) (p=0.001). This increase was driven by an increase in E. coli urinary tract
infections (UTI), particularly in older infants (31–90 days).
Conclusions: We observed a significant increase in E. coli UTI among FWLS infants with high rates of ampicillin resistance.
The reasons are likely to be multifactorial, but the results themselves emphasize the need to examine urine in all febrile
infants ,90days and consider local resistance patterns when choosing empiric antibiotics.
Citation: Watt K, Waddle E, Jhaveri R (2010) Changing Epidemiology of Serious Bacterial Infections in Febrile Infants without Localizing Signs. PLoS ONE 5(8):
e12448. doi:10.1371/journal.pone.0012448
Editor: Adam J. Ratner, Columbia University, United States of America
Received April 12, 2010; Accepted July 21, 2010; Published August 27, 2010
Copyright:  2010 Watt et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors have no support or funding to report.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ravi.jhaveri@duke.edu
Introduction
The management of infants ,90 days with fever without
localizing source (FWLS) has been a source of much controversy
and debate for the last 30 years. While the majority of these infants
will only have a minor viral or bacterial infection, the literature
reports that approximately 12% in those aged ,30days and 9% in
those 30–90 days will have a serious bacterial infection (SBI), such
as bacteremia, meningitis, or urinary tract infection (UTI)
[1,2,3,4]. In order to better predict those infants at risk for SBI,
Dagan et al evaluated a combination of clinical and laboratory data
(no focal exam, white blood cell count (WBC) between 5,000 and
15,000/mm
3, band forms ,1500/mm
3, normal urinalysis (UA)) to
identify low and high risk groups in what would become the
Rochester Criteria [5]. Modified criteria have followed that were
effective at identifying low risk infants, but differed in the exact
data included which resulted in inconsistent implementation
[6,7,8,9,10,11].
Several changes in the last 20 years have significantly altered the
epidemiology of SBI in neonates. Group B Streptococci (GBS) and E
coli have traditionally been the most important pathogens in this
age group. Institution of culture-based screening and prophylaxis
for GBS [12,13,14] has significantly lowered the incidence of this
pathogen. Additionally, several authors have noted possible
increased ampicillin resistance rates among pathogens causing
SBI in this age group [15,16]. In light of these changes, we
conducted this study of all infants less than 3 months of age with
FWLS over the last 10 years. The study questions were: What is
the current frequency and distribution of SBIs in these infants and
has this changed over time? What are the current rates of
antibiotic resistance in pathogens identified in these patients? How
do practitioners manage these patients?
Methods
The study was conducted at Duke University Hospital, a large,
tertiary care hospital in Durham, NC. Physicians in the Duke
Emergency Department (ED) see over 5500 children per year who
are less than 3 years of age. This project was reviewed and
approved by the Duke University Institutional Review Board. A
waiver of informed consent was obtained for this study because
this was a retrospective study examining hospital records
containing data derived for the purposes of clinical care.
Patient Identification
Using the Clinical Microbiology laboratory database, we
identified all children less than 90 days of age seen in the
emergent setting that had a blood culture performed from 1997–
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meeting criteria for FWLS and performed further analysis.
Patients were considered febrile if they had a history or
examination temperature of 38.0uC or higher. Temperatures
were measured rectally in the ED, and we included a fever
$38.0uC taken by the parents that was considered reliable by the
ED provider. Exclusion criteria were significant underlying illness
or past medical history (PMH), subjective reports of ‘‘feeling
warm’’ without a temperature taken, ill appearance, localizing
source of infection after a thorough physical examination, or
incomplete medical records. PMH could include history of
immunodeficiency, previous hospitalization, significant congenital
anomaly, or current antibiotic use. Complete records included
documented fever, presenting symptoms, physical findings, and
culture results.
Records were reviewed using the electronic medical record
including ED notes, discharge summaries, information on prior
and subsequent visits, and all laboratory and radiologic tests. For
each patient we recorded demographic information, pertinent
history, physical exam, and test results.
Definition of SBIs
Blood culture isolates were considered pathogens if the
organism is known to cause disease in healthy infants: Escherichia
coli, Staphylococcus aureus, Streptococcus pneumoniae, Enterococcus sp.,
Streptococcus agalactiae (GBS), Enterobacter cloacae, Klebsiella sp.,
Pasteurella sp., Moraxella sp., and Citrobacter sp. Organisms that
were considered contaminants included coagulase-negative Staph-
ylococci, Bacillus sp., Diptheroids, and Streptococcus viridans. Organisms
isolated from cerebrospinal fluid (CSF) were considered pathogens
if the organism was known to cause meningitis. To separate
colonization from infection, urine cultures were considered
positive if a known pathogen was isolated from a catheterized
specimen with .100,000 colony forming units (CFUs)/mL or
10,000–100,000 CFUs/mL with an abnormal urinalysis (UA) or in
a clean catch specimen if there were .100,000 CFUs/mL and an
abnormal UA. An abnormal UA was defined as positive leukocyte
esterase, nitrite, or $10 white blood cells (WBC)/hpf and with less
than 10 squamous epithelial cells/hpf. We analyzed all clinical
outcomes, initial choice of antibiotics, as well as any subsequent
changes made as a result of bacterial resistance or change in
patient’s clinical status.
Assignment of Low Risk/High Risk Status
Infants were classified as either low risk (LR) or high risk (HR)
based on historical, clinical and laboratory data. We applied the
practice guidelines of Baraff to our patients [11,17]. Infants were
considered LR if they were nontoxic appearing, previously
healthy, term infants with no focal source of infection upon
examination. While the Baraff guidelines considered all infants less
than 28d to be HR, we opted to only consider patients for LR
stratification if they were older than 30 days. The laboratory
criteria for LR patients included a WBC count of 5–15,000/mm
3,
,1500 bands/mm
3, negative gram stain of unspun urine or ,10
WBCs/hpf, and ,5 WBCs/hpf in stool when diarrhea is present.
Statistical Analysis
Statistical comparisons were performed using a two-tailed t-test
and chi-square testing for all numerical and categorical values,
respectively. Significance was set at p,0.05. We also performed a
Bayesian analysis to calculate unconditional probabilities of SBI
using a beta binomial with a (1,1) prior. This type of analysis
generates an unconditional probability rather than a conditional
one based on the null hypothesis being accepted or rejected [18].
Bayesian analysis also allows the incorporation of past studies/
experience into current data analysis to generate a probability
distribution that may be more clinically relevant. We generated
probability curves for SBIs in the early and later periods and
compared them to 2 other published SBI rates, the original
Rochester study and a more recent study from Utah [5,15]. We
used SPSS Version 15.0, an open-source, web based program
(www.openepi.com) and JMP7 (SAS) to perform the various
statistical testing.
Results
Between 1997–2006 1501 infants ,=90 days old had a blood
culture drawn for any reason in our ED. The numbers of patients
included in the final analysis are summarized in Table 1. Our
screening process for FWLS looked first for significant PMH, then
absence of fever, ill appearance, and focality of exam. We did
include infants born as young as 36 weeks if there was
documentation that they were routinely discharged and had no
underlying medical problems. After review, 668 patients (44.5%)
fit the criteria for FWLS and were included in the analysis. We
divided the time period into two 5-year blocks (1997–2001 and
2002–2006) that roughly approximated the time before and after
the transition from risk-based to culture-based screening for GBS
by the Duke Department of Obstetrics and Gynecology. The
earlier period included more infants in the youngest age group
(#30d), while the later period included more infants in the older
age group (61–90 days). Otherwise the groups were not
significantly different (Table 1). A total of 833 infants did not
meet criteria for FWLS, 386 with significant PMH, 355 who were
afebrile, 37 who were ill appearing, 29 with a focal exam, and 26
that had incomplete medical records. The majority of those with
significant PMH were former premature infants with a previous
NICU stay or infants born with a congenital anomaly (e.g.
congenital heart disease, shunted hydrocephalus) or immunode-
ficiency (e.g. SCID, HIV exposure). Most of the remainder had
either been hospitalized previously or were currently on
antibiotics.
Number and Rate of SBIs
The year by year results of our analysis are represented in
Figure 1A. The overall rate of SBIs in our study over 10 years was
10.8%, but closer analysis of the trend line reveals a marked
increase in SBIs during this ten year period (Figure 1B). When
Table 1. Patient Demographics.
1997–2001 2002–2006 p values
Eligible Infants 735 766
Included FWLS Infants 307 361
Male/Female 169/138 211/150 0.61
0–30d 104 97 0.05
31–60d 134 151 0.64
61–90d 69 113 0.01
HR/LR 178/129 204/157 0.70
Blood Cx performed* 307 361
UCx performed 259 321 0.08
LP Performed 233 235 0.002
*initial inclusion criteria so by definition encompasses all subjects.
doi:10.1371/journal.pone.0012448.t001
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#90d with a blood culture drawn increased over time (coef 0.43,
p,0.008) and the goodness of fit of our trend line showed a
modest association (R
2=0.61). When examined as two distinct
groups, infants in the later period had significantly more SBIs than
those in the earlier period (14.4% vs. 6.5%, p=0.001), with
increased UTIs accounting almost entirely for the difference (45
cases of UTI in the later period vs. 13 in the earlier period,
p=0.002) (Table 2).
Results from the Bayesian analysis comparing our data with that
from the original Rochester study and a more recent study from
Utah [5,15] are presented in Figure 2. The probability curves for
the Rochester and Utah studies overlap with the SBI probability
from the early period of our study. The SBI probability curve for
the later period of our study has very little overlap with the tail of
one of the other curves and no overlap with the others, reflecting a
distinct epidemiology among the infants in this group.
Breakdown of SBIs by type and age group
During the period of 1997–2001, 4.2% of the sample had
positive urine cultures, the majority of which were E. coli (84.6%)
(Table 3). From 2002–2006, 12.2% of the sample had positive
urine cultures (p=0.0002), almost all of which were E. coli (91.5%).
We did see patients that had two or more species of bacteria
isolated from their urine. Unless two distinct pathogens are
isolated, our lab reports multiple speciation as ‘‘mixed flora’’ and
these are considered contaminants and were not included as
positive UTIs. We did, however, count as positive two patients
Figure 1. Analysis of Raw Data and Trends in SBIs among FWLS Infants, 1997–2006. A) Raw numbers of FWLS infants as well as SBIs and %
SBI. B) Data in Figure 1a is graphed by %SBI on the y axis and year on the x axis (blue line). Also presented: overall mean %SBI (green line) and linear
regression (red line). Statistical data on linear regression line is included.
doi:10.1371/journal.pone.0012448.g001
Table 2. Types of Serious Bacterial Infections in Early and
Later periods.
1997–2001 2002–2006 p value
SBI 20 52 0.001
%SBI 6.5% 14.4%
UTI 13 45 0.0002
Bacteremia 7
a 11
b 0.54
Meningitis 12
c 0.64
aone patient had UTI+Bacteremia.
bfive patients had UTI+Bacteremia.
cone patient had Bacteremia+Meningitis.
doi:10.1371/journal.pone.0012448.t002
Figure 2. Bayesian Analysis of SBIs among FWLS Infants, 1997–
2001 and 2002–2006. The graph represents the probability of SBI
based on data from the early and later periods of this study compared
with the Rochester data as well as data on FWLS infants from Utah
[5,15]. The probability curve from the data from the later period centers
at approximately 14.4% whereas the other three curves all overlap
between 5–10% probabilities.
doi:10.1371/journal.pone.0012448.g002
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pathogenic species isolated by urine culture (Enterobacter and
Proteus; E. coli and Proteus). In the early period, one of the patients
with UTI had a concordant bacteremia, compared with five
patients in the later period, all of which were concordant E. coli
from each site.
There were 19 patients with a positive urine culture but ,10
WBCs on the UA, 5 in the early period and 14 in the late period.
In the early period, one of these patients met criteria for
colonization (clean catch specimen with .100,000 E. coli but
negative UA), and five patients from the later period met criteria
for colonization (3 with Enterococcus, one Pseudomonas, and one E.
coli).
There was no significant difference in episodes of bacteremia
with 7 cases (2.3% or 23 cases per 1000 infants with FWLS) in the
early period and 11 cases (3%) in the later period (p=0.54)
(Table 3). E. coli was responsible for 14.3% of cases in the early
period and 45.5% in the late. During the period of 2002–2006, we
saw 2 (0.6%) cases of meningitis. One of these was due to E. coli.
The blood culture for this patient was negative, but multiple
attempts to obtain a urine specimen were unsuccessful. The other
case was caused by Enterobacter cloacae in a patient that also had a
positive blood culture.
UTI rates were increased in all age groups, but the increase was
not statistically significant in the youngest infants (#30d) (Table 4).
Between 1997–2001 and 2002–2006 the rate of UTI amongst
infants #30d went from 3.8% to 7.2% (p=0.3). Amongst those
31–60d it went from 3.7% to 11.9% (p=0.01). In the infants age
61–90d the incidence of UTI increased from 5.8% to 17.7%
(p=0.02). There were no other significant differences between the
early and late period by age group though there was a trend
towards increasing bacteremia in the infants aged 0–60d.
Ampicillin Resistance
Ampicillin resistance for all SBI was 41.7% over the 10 year
period, 25% for the period 1997–2001 and 48.1% during the later
period 2002–2006 (p=0.08). Examining the UTI subset, the rate was
46.6% overall and, again, the difference between the early and late
Table 3. Bacterial Pathogens by Species and Site of Infection.
1997–2001 2002–2006
Pathogen Total # Pts Blood Urine CSF Total # Pts Blood Urine CSF
Gram-negative
Escherichia coli 11
a 11 1 - 4 4 5
b 43 1
Enterobacter cloacae -- - - 3 2 1
c 1
d
Citrobacter s p . 1 -1 - - ---
Proteus mirablis -- - - 3 - 3
e -
Moraxella cattarhalis - --- 1 1--
Pasteurella multocida - --- 1 1--
Gram-positive
Streptococcus pneumoniae 1 1-- - ---
Staphylococcus aureus 1 1-- - ---
Enterococcus sp. - - - - 1 1 - -
Streptococcus agalactiae (GBS) 54 1 - 11 - -
Listeria moncytogenes 1 --1 - ---
aOne infant with Ec o l ibacteremia had a concordant E coli UTI.
b5 infants with E coli bactermias had concordant Ec o l iUTIs.
cOne infant with Enterobacter UTI had a concomitant Proteus UTI.
dOne infant with Enterobacter meningitis also had a concordant Enterobacter bacteremia.
eOne infant with Ec o l iUTI had a concomitant Proteus UTI.
In 2002–2006, Total Patients with SBI=54; Actual number is 52 – this discrepancy is due to the fact that one patient had a Enterobacter and Proteus UTI and one patient
had a Proteus and E coli UTI.
doi:10.1371/journal.pone.0012448.t003
Table 4. SBIs by Age Group.
Age 1997–2001 2002–2006
SBI UTI Bacteremia Meningitis SBI UTI Bacteremia Meningitis p value-UTI
0–30 days 7
a 43 1 9
b 7 5 - 0.30
31–60 days 85 3 - 2 2
c 18 6 1 0.01
61–90 days 5 4 1 - 21 20 - 1 0.02
a1 UTI was urosepsis.
b3 UTIs were urosepsis.
c2 UTIs were urosepsis, 1 meningitis had concomitant bacteremia.
doi:10.1371/journal.pone.0012448.t004
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was changed in a third of cases of SBI after antibiotic sensitivities were
known. The six patients with ampicillin resistant gram negative rod
bacteremia (1 from the early period, 5 from the later period) all had
antibiotics switched when sensitivities were known and all had longer
antibiotic courses compared to non-bacteremic infants. Four of those
patients stayed at least 2 extra days in the hospital and the other two
kept indwelling venous catheters for at least 2 extra days.
Management of FWLS Infants
Management differed both over time and between age groups
(Table 5). Among the age groups over the 10 year period almost all
infants 30d or less received a complete workup including collection of
blood, urine, and CSF cultures. There was no statistical difference in
urine studies performed between the younger (#30d) and older (31–
90d) infants (p=0.54), but older infants (31–90d) had significantly
fewer LPs performed and antibiotics given than younger infants
(p,0.001).Among those older infants that werestratified as HR, only
66.9% had an LP performed which is highly significant compared
with the infants less than 30d old (p,0.001). Comparing 1997–2001
with 2002–2006, there were significantly fewer LPs performed
(p=0.002) and antibiotics given (p=0.0004) in the later period.
Discussion
The purpose of this study was to investigate the rates of SBI,
patterns of antibiotic resistance, and practitioner management,
given the possible changing epidemiology. In our analysis, we
identified several trends that may impact the care and outcomes of
this group. The most significant was a major increase in the rate of
SBI, arising predominantly from increased rates of E. coli UTIs
which has not been previously reported. This increase is
particularly pronounced when compared to previous studies.
The original Rochester study had an SBI rate of 10%, but they
included infants with a focal exam in their study which would have
resulted in higher rates of SBI [5]. A more recent study from Utah
demonstrated an 8% SBI rate [15]. Our 2002–2006 SBI rate of
14.4% is markedly higher. The reasons for this increase are not
entirely clear, but we hypothesize several potential factors that
may have contributed in some way to this increase.
The first is widespread intrapartum antibiotic prophylaxis (IAP)
for GBS may be selecting for gram negative bacteria that have a
propensity to cause disease in young infants. Many studies have
examined IAP ampicillin use and found no increase neonatal E.
coli sepsis [19,20,21,22]. In contrast, two studies found that infants
with invasive E. coli were more likely to have been exposed to IAP
[23,24]. Our hospital pharmacy data indicates that from 2002–
2006, which are the earliest years available, approximately 20–
30% of pregnant women received ampicillin. One would expect
that if IAP was the primary reason for the increase, most of the
cases would be among the youngest infants closest to the exposure
during delivery. Our data shows the opposite, that the burden of
UTI is spread disproportionately among the older infants.
Another potential reason is the emergence of a new clone that
coincided with the switch in GBS prophylaxis at our institution.
Clonal group A is known as a multidrug resistant uropathogenic
group known to cause UTIs in adults [25]. Its epidemiology in
infants is unknown. The other possibility is E. coli expressing the
Dr adhesins that are usually associated with pregnancy related
UTIs may have crossed into the infant population [26]. We are
currently initiating studies of stored E. coli isolates to investigate
this clonal possibility.
Another potential contributor is the lower rate of circumcisions
over the past several years, which would increase a patient pool at
higher risk of UTI [27,28,29]. NC Medicaid stopped paying for
circumcision permanently starting November, 2002 with a
resulting drop in the circumcision rate from 74% in 2000 to
40% in 2004 [30]. While this remains a possible explanation, it is
noteworthy that male to female distribution of SBIs did not change
significantly over the 10-year period.
Another possible explanation is sampling error and/or selection
bias. We selected our patient population from those infants seen by
physicians in the ED who had a blood culture drawn for any
reason. It is possible that there were infants who presented to our
ED with FWLS who did not have a blood culture drawn and if
these infants did not subsequently develop an SBI that would
mean our rates are artificially high. We also noted that there were
more infants excluded in the early period compared to the later
period for insufficient data. This is likely a reflection of the
transitional years from a combined paper and electronic record to
the current electronic one, but that difference could not explain
the differences between the two periods.
Regardless of the reason, our results emphasize the need to
sample urine on every infant less than 90 days of age. While
practitioners are doing a better job at collecting urine studies, even
at 93.4% of patients with a urine evaluation, with a 12.2% UTI
rate in the 2002–2006 period out of the 361 FWLS infants, 2–3
UTIs were potentially missed.
The second important issue our results raise relates to antibiotic
resistance. Ampicillin, in combination with gentamicin, has been
traditionally used in the younger infants for its efficacy against
Table 5. Management of Infants with FWLS in Early and Later
periods.
1997–2006
0–30 31–60 61–90 All ages
# patients 201 285 182 668
LP Performed 188 (93.5) 202 (70.9) 78 (42.9) 468
UCx Performed 177 (88.1) 253 (88.8) 150 (82.4) 606
Antibiotics given 196 (97.5) 245 (86) 121 (66.5) 562
1997–2001
# patients 104 134 69 307
LP Performed 97 (93.3) 104 (77.6) 32 (46.4) 233
UCx Performed 88 (84.6) 121 (90.3) 50 (72.5) 259
Antibiotics given 101* (97.1) 123** (91.8) 51** (73.9) 275
2002–2006
# patients 97 151 113 361
LP Performed 91 (93.8) 98 (64.9) 46 (40.7) 235
UCx Performed 89 (91.8) 132 (87.4) 100 (88.5) 321
Antibiotics given 95 (97.9) 122
# (80.8) 70‘ (61.9) 287
Comparing older infants (31–90d) vs. younger (#30d):
fewer LP’s performed (p,0.001);
no difference in UCx’s performed (p=0.54);
significantly fewer antibiotics given (p,0.001).
Comparing 2002–2006 vs. 1997–2001 overall (i.e. not broken down by age
group):
significantly fewer LPs performed (p=0.002);
no difference in UCxs performed (p=0.08);
significantly less antibiotics given (p=0.0004).
*Unknown if abx given to 1pt.
**Unknown if abx given to 2pts.
#Unknown if abx given to 1pt.
‘Unknown if abx given to 3pts.
doi:10.1371/journal.pone.0012448.t005
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majority of pathogens were gram negative bacteria with high rates
of ampicillin resistance [16]. They observed no cases of Listeria
over a 4 year period. In 2003, Byington et al found similar results
over a 3-year period [15]. In our study, 80% of disease was caused
by E. coli with high rates of ampicillin resistance. We would argue
that empiric antibiotics should cover the most likely invasive
pathogen and appropriately account for the risk of antibiotic
resistance. The vast majority of isolates causing UTI would no
doubt respond to a regimen of ampicillin and gentamicin given the
latter’s utility in treating UTI. However, 8–9% of the SBIs in these
infants would be a case of bacteremia or meningitis with an
ampicillin resistant E. coli (5/52 from 2002–2006, 6/70 overall), a
situation where most practitioners would not consider what
effectively would be gentamicin monotherapy as appropriate. As
a comparison, vancomycin plus cefotaxime/ceftriaxone is recom-
mended in S. pneumoniae meningitis where the risk of cefotaxime/
ceftriaxone non-susceptibility is approximately 7% [31]. We would
suggest that careful attention be paid to local resistance rates in this
infant population, and perhaps in a setting with resistance rates as
high as ours, an empiric regimen of ampicillin and cefotaxime
would appropriately cover virtually all likely pathogens in this
patient population.
Our study also shows that practitioners perform much less
aggressive evaluations on older infants. At first glance this may
seem appropriate since these patients are old enough to be
stratified as HR or LR and, if LR, receive a more limited
evaluation. However, when the older infants were analyzed by risk
according to the Baraff guidelines [17], we found that only 66.9%
of HR patients received an LP, suggesting that guidelines are only
inconsistently followed. Given the concern that UTI in this age
group puts infants at risk for meningitis and our own observation
that one of our infants was diagnosed with concomitant UTI and
meningitis, it still seems reasonable that all high-risk patients
should receive an LP.
Our findings should be analyzed in light of certain limitations.
This is a retrospective study from a single center, and the volume
and patient population seen in our ED may not be generalizable to
larger practice settings. This study should be repeated at other
institutions to see if the increase in UTIs is present. Our inability to
determine the number of febrile children that did not receive a
blood culture in the ED means that our frequencies of FWLS may
be falsely high and our total rates of SBI also may be falsely high.
This, in turn, limits our ability to draw comparisons with other
studies, such as the Utah study, where data was collected
prospectively on all infants with fever [15]. There are limitations
with applying criteria retrospectively since some classification data
may not have been recorded in the chart.
In this study, we have observed a significant increase in the
number of SBI in infants with FWLS. These were primarily UTIs
and the reasons for this are not yet clear. These results reinforce
the need to examine the urine in all of these infants regardless of
risk stratification and age. Our results also further suggest a move
away from the combination of ampicillin and gentamicin as
primary empiric therapy. The data from this study also may assist
to streamline the management of these infants by helping to
delineate risk differences in older versus younger infants.
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